CGH
ELAN icon

Crossmark Global Holdings’s Elanco Animal Health ELAN Stock Holding History

Crossmark Global Holdings’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Buy
39,372
+2,917
+8% +$67.4K 0.01% 634
2026
Q1 		$872K Buy
36,455
+26,779
+277% +$655K 0.01% 651
2025
Q4 		$219K Buy
+9,676
New +$211K ﹤0.01% 1154

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Crossmark Global Holdings's ELAN Position: Q2 2026 in Review

Crossmark Global Holdings increased its Elanco Animal Health (ELAN) stake by 8% in Q2 2026, buying an estimated $67.4K and bringing the position to 39,372 shares worth $969K. The position accounts for 0.01% of the portfolio, ranked #634.

Crossmark Global Holdings first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Crossmark Global Holdings held 39,372 shares of Elanco Animal Health worth $969K as of Q2 2026.
  • Crossmark Global Holdings bought 2,917 Elanco Animal Health shares in Q2 2026, an estimated $67.4K.
  • Elanco Animal Health made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #634 holding.
  • Crossmark Global Holdings first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.